Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...
Saudi Arabia approves Anktiva, an IL-15 immunotherapy, for bladder and lung cancer, marking its first regulatory clearance ...
On the steps of San Francisco City Hall, firefighters joined forces to fight for one of their own: retired firefighter Ken ...
Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.